Metraipolis › archive › dc_e5df12c6dc96
Mapping Human Clinical Evidence for Chikungunya Vaccines: A Scoping Review of Immunogenicity, Durability, and Safety — Europe PMC PMID:42506635
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42506635
- DOI
- 10.3390/vaccines14070598
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T10:48:56.964Z
- SHA-256 of the archived text
7197a5452141c438a27e14ed1ec70b03d98f222cd80d92140b091a0082bfff14- Stable URL of this page
https://metraipolis.com/documento/dc_e5df12c6dc96
How to cite
Mapping Human Clinical Evidence for Chikungunya Vaccines: A Scoping Review of Immunogenicity, Durability, and Safety — Europe PMC PMID:42506635 — Europe PMC (en), https://europepmc.org/article/MED/42506635 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e5df12c6dc96 (Metraipolis archive dc_e5df12c6dc96, sha256 7197a5452141c438a27e14ed1ec70b03d98f222cd80d92140b091a0082bfff14)
BibTeX
@misc{dce5df12c6dc96,
title = {Mapping Human Clinical Evidence for Chikungunya Vaccines: A Scoping Review of Immunogenicity, Durability, and Safety — Europe PMC PMID:42506635},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42506635},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e5df12c6dc96; sha256 7197a5452141c438a27e14ed1ec70b03d98f222cd80d92140b091a0082bfff14},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42506635. Agents can read the archived copy with the MCP tool read_document.